RxDoctor Payments Data

Beth Lewis

Family · Jesup, GANPI 1205457264

Payments from drug & device makers

$3,547in general payments, 2019–2025

Across 164 payments — averaging $21.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$689
  • Regeneron Healthcare Solutions, Inc.$468
  • Takeda Pharmaceuticals U.S.A., Inc.$389
  • GSK$379
  • Inspire Medical Systems, Inc.$317
  • Mallinckrodt Hospital Products Inc.$273
  • plus $1K from 12 others

What the payments were for

  • Food & beverage$3,34794%
  • Education$2006%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,547 in reported general payments places this provider in the 85th percentile of 6,258 family providers in Georgia.

See all family providers in Georgia

Medicare billing

Part B allowed, 2024
$26,210
Medicare patients
199
Services billed
517

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter140$139,496
Breztri AerosphereBudesonide/Glycopyr/Formoterol75$83,495
Breo ElliptaFluticasone/Vilanterol53$26,929
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr31$21,491
EliquisApixaban23$17,677
SymbicortBudesonide/Formoterol Fumarate38$12,858
Stiolto RespimatTiotropium Br/Olodaterol Hcl17$10,633
Combivent RespimatIpratropium/Albuterol Sulfate12$6,786
Spiriva RespimatTiotropium Bromide12$6,379
Fluticasone-SalmeterolFluticasone Propion/Salmeterol34$6,337
Albuterol Sulfate HfaAlbuterol Sulfate196$5,627
Fluticasone Propionate228$4,236
Azelastine Hcl81$3,394
Wixela InhubFluticasone Propion/Salmeterol21$2,920
Roflumilast22$2,033

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta$379$187,915224 claims
AstraZenecaBreztri Aerosphere, Symbicort$689$96,353113 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 6,258 family providers in Georgia.

Other family in Jesup

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →